Skip to main content

Advertisement

Log in

Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract

Virchows Archiv Aims and scope Submit manuscript

Abstract

L-type amino acid transporter 1 (LAT1), a neutral amino acid transporter, requires covalent association with the heavy chain of 4F2 cell surface antigen (4F2hc) for its functional form. We investigated the importance of LAT1 and 4F2hc expressions to progression in upper urinary tract cancer. We examined their expressions and their relationships to clinicopathologic parameters and clinical outcome in 124 cases. Positive expressions of LAT1 (protein and messenger ribonucleic acid) and 4F2hc (protein) were recognized in 79.8, 89.5, and 87.9% of tumor samples, respectively. In tumor cells, LAT1 protein was detected either as nodular granules within the cytoplasm or diffusely within the cytoplasm and/or on plasma membrane. In the normal urothelium, its expression was detected as nodular granules within the cytoplasm. A correlation with stage was shown for LAT1 protein expression and for a cooperative expression of LAT1 protein with 4F2hc protein (active form of LAT1 protein). Further, in all tumors, a cooperative expression of LAT1 protein and 4F2hc protein was significantly correlated with both overall and disease-free survival rates in the univariate analysis but not in the multivariate analysis. In conclusion, the detection of the active form of LAT1 protein would appear to be of value in informing the risk of progression in transitional cell carcinoma of the upper urinary tract.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Campbell WA, Thompson NL (2001) Overexpression of LAT1/CD98 light chain is sufficient to increase system L-amino acid transport activity in mouse hepatocytes but not fibroblasts. J Biol Chem 276:16877–16884

    Article  PubMed  CAS  Google Scholar 

  2. Chillaron J, Roca R, Valencia A, Zorzano A, Palacin M (2001) Heteromeric amino acid transporters: biochemistry, genetics, and physiology. Am J Physiol Renal Physiol 281:F995–F1018

    PubMed  CAS  Google Scholar 

  3. Christensen HN (1990) Role of amino acid transport and countertransport in nutrition and metabolism. Phys Rev 70:43–77

    CAS  Google Scholar 

  4. Das AK, Carson CC, Bolick D, Paulson DF (1990) Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival. Cancer 66:1919–1923

    Article  PubMed  CAS  Google Scholar 

  5. Fuchs BC, Bode BP (2005) Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol 15:254–266

    Article  PubMed  CAS  Google Scholar 

  6. Huben RP, Mounzer AM, Murphy GP (1988) Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 62:2016–2020

    Article  PubMed  CAS  Google Scholar 

  7. Kanai Y, Endou H (2001) Heterodimeric amino acid transporters: molecular biology and pathological and pharmacological relevance. Curr Drug Metab 2:339–354

    Article  PubMed  CAS  Google Scholar 

  8. Kanai Y, Endou H (2003) Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity. J Toxicol Sci 28:1–17

    Article  PubMed  CAS  Google Scholar 

  9. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H (1998) Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 273:23629–23632

    Article  PubMed  CAS  Google Scholar 

  10. Kim do K, Ahn SG, Park JC, Kanai Y, Endou H, Yoon JH (2004) Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in oral squamous cell carcinoma and its precursor lesions. Anticancer Res 24:1671–1675

    PubMed  Google Scholar 

  11. Kim DK, Kanai Y, Choi HW, Tangtrongsup S, Chairoungdua A, Babu E, Tachampa K, Anzai N, Iribe Y, Endou H (2002) Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. Biochim Biophys Acta 1565:112–121

    Article  PubMed  CAS  Google Scholar 

  12. Kim do K, Kim IJ, Hwang S, Kook JH, Lee MC, Shin BA, Bae CS, Yoon JH, Ahn SG, Kim SA, Kanai Y, Endou H, Kim JK (2004) System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells. Neurosci Res 50:437–446

    Article  PubMed  Google Scholar 

  13. Kobayashi H, Ishii Y, Takayama T (2005) Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma. J Surg Oncol 90:233–238

    Article  PubMed  CAS  Google Scholar 

  14. Li R, Younes M, Frolov A, Wheeler TM, Scardino P, Ohori M, Ayala G (2003) Expression of neutral amino acid transporter ASCT2 in human prostate. Anticancer Res 23:3413–3418

    PubMed  CAS  Google Scholar 

  15. Mastroberardino L, Spindler B, Pfeiffer R, Skelly PJ, Loffing J, Shoemaker CB, Verrey F (1998) Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature 395:288–291

    Article  PubMed  CAS  Google Scholar 

  16. Matsuo H, Tsukada S, Nakata T, Chairoungdua A, Kim DK, Cha SH, Inatomi J, Yorifuji H, Fukuda J, Endou H, Kanai Y (2000) Expression of a system L neutral amino acid transporter at the blood-brain barrier. NeuroReport 11:3507–3511

    Article  PubMed  CAS  Google Scholar 

  17. Murphy WM, Beckwith JB, Farrow GM (1994) Tumors of the kidney, bladder, and related urinary structures. Atlas of tumor pathology, Third Series, fasc. 11. Armed Forces Institute of Pathology, Washington, DC, pp 202–219

    Google Scholar 

  18. Nakanishi K, Hiroi S, Tominaga S, Aida S, Kasamatsu H, Matsuyama S, Matsuyama T, Kawai T (2005) Expression of HIF-1α protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. Clin Cancer Res 11:2583–2590

    Article  PubMed  CAS  Google Scholar 

  19. Nakanishi K, Kawai T, Sato H, Aida S, Kasamatsu H, Aurues T, Ikeda T (2000) Expression of matrix metalloproteinase-2 (MMP-2) and of membrane-type-1-matrix metalloproteinase (MT1-MMP) in transitional cell carcinoma of the upper urinary tract. Human Pathol 31:193–200

    Article  CAS  Google Scholar 

  20. Nakanishi K, Kawai T, Suzuki M, Torikata C (1996) Growth factors and oncogene products in transitional cell carcinoma. Mod Path 9:292–297

    CAS  Google Scholar 

  21. Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T (1997) E-cadherin expression in upper-urinary-tract carcinoma. Int J Cancer 74:446–449

    Article  PubMed  CAS  Google Scholar 

  22. Nakanishi K, Kawai T, Torikata C (1996) Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract. Human Pathol 27:1336–1340

    Article  CAS  Google Scholar 

  23. Nakanishi K, Matsuo H, Kanai Y, Endou H, Hiroi S, Tominaga S, Mukai M, Ikeda E, Ozeki Y, Aida S, Kawai T (2006) LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Virchows Arch 448:142–150

    Article  PubMed  CAS  Google Scholar 

  24. Nakanishi K, Tominaga S, Kawai T, Torikata C, Aurues T, Ikeda T (1998) Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract. Virchows Arch 432:445–450

    Article  PubMed  CAS  Google Scholar 

  25. Ohkame H, Masuda H, Ishii Y, Kanai Y (2001) Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat models. J Surg Oncol 78:265–271

    Article  PubMed  CAS  Google Scholar 

  26. Ritchie JW, Taylor PM (2001) Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta. Biochem J 356:719–725

    Article  PubMed  CAS  Google Scholar 

  27. Sang J, Lim YP, Panzica M, Finch P, Thompson NL (1995) TA1, a highly conserved oncofetal complementary DNA from rat hepatoma, encodes an integral membrane protein associated with liver development, carcinogenesis, and cell activation. Cancer Res 55:1152–1159

    PubMed  CAS  Google Scholar 

  28. SAS technical report P-217, SAS/STAT software (1991) The PHREG Procedure, version 6. SAS Institute, Cary, NC, p 63

  29. Segawa H, Fukasawa Y, Miyamoto K, Takeda E, Endou H, Kanai Y (1999) Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 274:19745–19751

    Article  PubMed  CAS  Google Scholar 

  30. Shennan DB, Thomson J, Barber MC, Travers MT (2003) Functional and molecular characteristics of system L in human breast cancer cells. Biochim Biophys Acta 1611:81–90

    Article  PubMed  CAS  Google Scholar 

  31. Tamai S, Masuda H, Ishii Y, Suzuki S, Kanai Y, Endou H (2001) Expression of L-type amino acid transporter 1 in a rat model of liver metastasis: positive correlation with tumor size. Cancer Detec Prev 25:439–445

    PubMed  CAS  Google Scholar 

  32. UICC (International Union Against Cancer) (2002) Renal pelvis and ureter. TNM classification of malignant tumours, 6th edn. Wiley-Liss, New York, pp 196–198

    Google Scholar 

  33. Witte D, Ali N, Carlson N, Younes M (2002) Overexpression of the neutral amino acid transporter ASCT2 in human colorectal adenocarcinoma. Anticancer Res 22:2555–2557

    PubMed  CAS  Google Scholar 

  34. Wolf DA, Wang S, Panzica MA, Bassily NH, Thompson NL (1996) Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Cancer Res 56:5012–5022

    PubMed  CAS  Google Scholar 

  35. Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, Cha SH, Matsuo H, Fukushima J, Fukasawa Y, Tani Y, Taketani Y, Uchino H, Kim JY, Inatomi J, Okayasu I, Miyamoto K, Takeda E, Goya T, Endou H (2001) Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 1514:291–302

    Article  PubMed  CAS  Google Scholar 

  36. Yoon JH, Kim YB, Kim MS, Park JC, Kook JK, Jung HM, Kim SG, Yoo H, Ko YM, Lee SH, Kim BY, Chun HS, Kanai Y, Endou H, Kim do K (2004) Expression and functional characterization of the system L amino acid transporter in KB human oral epidermoid carcinoma cells. Cancer Lett 205:215–226

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The authors are indebted to Dr. R. Timms for correcting the English. Anti-LAT1 and anti-4F2hc antibodies were supplied by Kumamoto Immunochemical Laboratory, Trans Genic, Kumamoto, Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kuniaki Nakanishi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakanishi, K., Ogata, S., Matsuo, H. et al. Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract. Virchows Arch 451, 681–690 (2007). https://doi.org/10.1007/s00428-007-0457-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-007-0457-9

Keywords

Navigation